GLP-1 drugsReview

Chilean Multidisciplinary Consensus on the Use of GLP-1 Receptor Agonists: Recommendations Based on the GRADE Methodology

Revista Medica de Chile

The paper

Sebastian cabrera, Magdalena Walbaum, Tamara Bórquez,

Catalina Fuentes, Mónica Acevedo, Paola Varleta, Pamela Belmar, Patricia Gómez, María Gabriela Sanzana, J. De la Vega, Gustavo Navarro, Carla Saavedra, Mario Hernandez, Sabrina Gomez,

Sociedad Chilena de Nefrología

Revista Medica de Chile · 1 Jul 2026

doi.org/10.4067/s0034-98872026000701070 PubMed 42809786

GLP-1 agonists plus SGLT2 inhibitors lower kidney events in CKD
Diabetes, Obesity & Metabolism · 4 Oct 2026
SGLT2 inhibitors match GLP-1 drugs for overall kidney outcomes
Clinical Journal of the American Society of Nephrology · 4 Oct 2026
SGLT2 inhibitors link to lower dementia risk than GLP-1 drugs
Diabetes & Vascular Disease Research · 4 Oct 2026
GLP-1 receptor agonists link to lower stroke and Alzheimer risk
Neurology Genetics · 4 Oct 2026